Exelixis (EXEL) Consolidated Net Income (2010 - 2026)

Exelixis' (EXEL) quarterly Consolidated Net Income came in at $210.5 million in Q2 2026, up 31.86% year-on-year from $159.6 million in Q2 2025, and down 13.93% quarter-over-quarter from $244.5 million in Q1 2026.

Exelixis (EXEL) Consolidated Net Income (2010 - 2026) Analysis & Trends

Exelixis' Consolidated Net Income history runs 17 years deep, the most recent figure standing at $210.5 million for Q2 2026.

  • On a quarterly basis, Consolidated Net Income rose 31.86% year-over-year to $210.5 million in Q2 2026; TTM through Apr 2026 was $833.4 million, a 29.5% increase from a year earlier, with the FY2026 full-year figure at $782.6 million, up 50.13% from the prior year.
  • Consolidated Net Income slipped to $210.5 million in Q2 2026 per EXEL's latest filing, from $244.5 million in the prior quarter.
  • Across five years, Consolidated Net Income topped out at $244.5 million in Q1 2026 and bottomed at -$30.2 million in Q4 2022.
  • The 5-year median for Consolidated Net Income is $85.5 million (2023), against an average of $112.0 million.
  • Across the five-year window, Consolidated Net Income plunged 131.71% in 2022 and soared 11232.66% in 2024, its largest moves.
  • Year by year, Consolidated Net Income stood at -$30.2 million in 2022, then surged by 383.43% to $85.5 million in 2023, then jumped by 37.95% to $118.0 million in 2024, then jumped by 64.09% to $193.6 million in 2025, then increased by 8.72% to $210.5 million in 2026.
  • Per Business Quant, the three latest EXEL Consolidated Net Income figures stand at $210.5 million (Q2 2026), $244.5 million (Q1 2026), and $193.6 million (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Consol Net Inc. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -37.09 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -3.68 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 727.20 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 Exelixis 14.38 Bn 13.60 Bn 590.86 Mn 210.47 Mn

Historic Data

Download Data
DateValue
Apr 3, 2026 210.47 Mn
Jan 2, 2026 244.53 Mn
Oct 3, 2025 193.58 Mn
Jul 4, 2025 184.85 Mn
Apr 4, 2025 159.62 Mn
Jan 3, 2025 139.86 Mn
Sep 27, 2024 117.97 Mn
Jun 28, 2024 226.12 Mn
Mar 29, 2024 37.32 Mn
Dec 29, 2023 85.52 Mn
Sep 29, 2023 1.04 Mn
Jun 30, 2023 81.18 Mn
Mar 31, 2023 40.03 Mn
Dec 30, 2022 -30.17 Mn
Sep 30, 2022 73.21 Mn
Jul 1, 2022 70.67 Mn
Apr 1, 2022 68.57 Mn
Dec 31, 2021 95.17 Mn
Oct 1, 2021 38.20 Mn
Jul 2, 2021 96.09 Mn